General Western Blot Reagents
Abcam Sp-5,6-Dichloro-cBIMPS, cAMP-dependent protein kinase activator, 1MG
MW 419.2 g/mol, Purity >98%. cAMP analog. Cell-permeable, potent activator of cAMP-dependent protein kinase (PKA; Ka = 30 nM); Selective for PKA over cGMP-dependent protein kinase (PKG; Ka = 10 μM). Not significantly hydrolyzed by type I, II or III phosphodiesterases.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Tetramethylrhodamine-5-maleimide, Labeling reagent for protein thiols, 5MG
MW 481.5 g/mol, Purity >85%. Thiol reactive fluorescent probe for use in cytofluorescence. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Quinol 2, Antitumor agent, 5MG
MW 243.28 Da, Purity >99%. Selective antitumor agent. Active against colon, renal and breast carcinomas in vitro and ex vivo. Inhibits thioredoxin reductase with potencies correlated with antiproliferative and cytotoxic effects. Potent inhibitory effect in NCI 60 cells (GI₅₀ =0.23 μM and LC₅₀ = 3.39 μM).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Indican Assay Kit.
Indican Assay Kit.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 10X Dilution Buffer
10X Dilution Buffer
The product is subject to the following: Abcam Restricted Use Statement
Abcam HDAC1 Sumoylation Assay Kit.
HDAC1 Sumoylation Assay Kit.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Glucose Oxidase Activity Assay Kit (Colorimetric)
Glucose Oxidase Activity Assay Kit (Colorimetric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam Imiquimod, Toll-like receptor 7 agonist, 500MG
MW 240.3 Da, Purity >95%. Toll-like receptor 7 agonist. Activates NF-κB and stimulates pro-inflammtory cytokines. Immunomodulator, antiviral and antitumor agent. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Concanamycin B, H+-ATPase inhibitor, 100UG
MW 852.1 Da, Purity >98%. Potent, selective vacuolar type H+-ATPase inhibitor. Antibiotic agent. Induces EGF-dependent apoptosis. Shows similar effects as Concanamycin A (ab144227) and Concanamycin C (ab144229). Shows potent antiviral effects (IC50 = 6 nM, HSV-1 replication).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Concanamycin C, H+-ATPase inhibitor, 500UG
MW 823.1 Da, Purity >98%. Potent, selective vacuolar-type H+-ATPase inhibitor. Macrolide antibiotic agent. Concanamycin A (ab144227) analog. Shows antiproliferative and potent antifungal effects.
The product is subject to the following: Abcam Restricted Use Statement
![Abcam Alexa Fluor 405 Rabbit IgG, monoclonal [EPR25A] Isotype Control](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502588696.png-250.jpg)
Abcam Alexa Fluor 405 Rabbit IgG, monoclonal [EPR25A] Isotype Control
Alexa Fluor 405 Rabbit IgG, monoclonal [EPR25A] Isotype Control
The product is subject to the following: Abcam Restricted Use Statement
Abcam cis-Resveratrol, Antio x idant agent, 100MG
MW 228.24 Da, Purity >98%. Antioxidant agent. NADPH oxidase inhibitor. Blocks ROS production. Resveratrol (ab120726) isomer. Inhibits canonical and non-canonical inflammasomes in macrophages. Shows anti-inflammatory and antiproliferative effects. Orally bioavailable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ceftria x one disodium salt hemi(heptahydrate), beta-Lactam antibiotic, 50MG
MW 1323.2 Da, Purity >98%. Ceftriaxone disodium salt hemi(heptahydrate), beta-Lactam antibiotic. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 271046 hydrochloride, 5-HT6 antagonist, 10MG
MW 488.45 g/mol, Purity >99%. Potent and selective 5-HT₆ receptor antagonist (Ki = 1-2 nM). Displays >200-fold selectivity for 5-HT₆ receptors (vs. other receptor binding sites and ion channels). Poor penetration of the blood-brain barrier. Nootropic effects in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 271046 hydrochloride, 5-HT6 antagonist, 50MG
MW 488.45 g/mol, Purity >99%. Potent and selective 5-HT₆ receptor antagonist (Ki = 1-2 nM). Displays >200-fold selectivity for 5-HT₆ receptors (vs. other receptor binding sites and ion channels). Poor penetration of the blood-brain barrier. Nootropic effects in vivo.
The product is subject to the following: Abcam Restricted Use Statement